We use cookies to track usage and optimise user experience. By continuing to browse and use the site you are agreeing to our use of cookies.

Urology in the COVID-19 era - how do we transition to the "new normal"?

18th May 2020

Overview

RCSEd has partnered with BAUS to outline the current position of Urology during the COVID-19 Pandemic and discuss how the Specialty can move from the current, very curtailed level of service towards a more normal degree of activity, given that restrictions are likely to be in place for some time to come.

BAUS has recently produced guidance on how best to re-introduce urological activity in general terms and more detailed sub-specialist guidance from the Sections of Oncology, Endourology, FNUU and Andrology. This Webinar is an opportunity to hear more detail on the guidance and ask questions of the BAUS team involved in their development.

Duncan Summerton, President of BAUS will be joined by the four Sub-Specialty Section Chairs to outline the guidance and discuss how Urology can move forward in a Question and Answer session.

Panellists

  • Duncan Summerton BSc(Hon) MB ChB FRCSEng FRCSEd FRCS(Urol)
    Consultant Urological Surgeon, Leicester General Hospital.
    President of BAUS
  • Ben Challacombe BSc(Hon) MBBS(Hon) MS FRCS (Urol)
    Consultant Urological Surgeon, Guy’s and Thomas’s Hospital, London.
    Chair of the BAUS Section of Oncology
  • Sheilagh Reid MB BCh BAO, FRCS Urol
    Consultant Urological Surgeon, Northern General Hospital, Sheffield.
    Chair of the BAUS Section of Female, Neurological and Urodynamic Urology
  • Majid Shabbir BSc(Hons), MD, FRCS(Urol)
    Consultant Urological Surgeon, Guy’s and Thomas’s Hospital, London.
    Chair of the BAUS Section of Andrology and Genito-Urethral Surgery
  • Daron Smith MA(Cantab) BM BCh(Oxon) FRCSEng MD FRCS(Urol)
    Consultant Urological Surgeon, University College Hospital, London.
    Chair of the BAUS Section of Endourology

Recording


back to top of page